Login / Signup

A multicenter, prospective, randomized clinical trial of marine mussel-inspired adhesive hemostatic materials, InnoSEAL Plus.

Gyu Seong ChoiSeoung Hoon KimHyung Il SeoJe Ho RyuSung Pil YunMi-Young KohMoon Sue LeeHaeshin LeeJae-Hoon Kim
Published in: Annals of surgical treatment and research (2021)
Given that InnoSEAL Plus is a coagulation factor-free product, the hemostasis results are encouraging, especially considering that TachoSil contains a coagulation factor. InnoSEAL Plus was found to be a safe and effective hemostatic material for control of bleeding in hepatectomy patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • atrial fibrillation
  • double blind
  • clinical trial